| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/22/2001 | WO2001012217A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012208A1 Use of ginkgo extract |
| 02/22/2001 | WO2001012206A2 Soy-glycine extracts and aromatase inhibitors for positively influencing collagen |
| 02/22/2001 | WO2001012199A2 Methoxyamine potentiation of temozolomide anti-cancer activity |
| 02/22/2001 | WO2001012193A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 02/22/2001 | WO2001012189A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | WO2001012188A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | WO2001012182A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012169A2 Method of cancer treatment |
| 02/22/2001 | WO2001012168A2 Antiviral pharmaceutical compositions containing iron chelators |
| 02/22/2001 | WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077246A3 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000072008A3 Identification of novel mechanisms of drug resistance |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000071156A3 New vaccine formulations-3 |
| 02/22/2001 | WO2000071155A3 New vaccine formulations - 2 |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/22/2001 | WO2000062808A3 Cobalamin conjugates useful as antitumor agents |
| 02/22/2001 | WO2000058483A3 Protozoan expression system |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO2000039716A3 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO1999050275A3 Macrolide lhrh antagonists |
| 02/22/2001 | WO1999046279A3 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides |
| 02/22/2001 | DE19938671A1 New nucleic acid encoding cerebral sphingomyelinase, useful e.g. for diagnosis and treatment of inflammation and cancer |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2452118A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | CA2393965A1 Ascididemin derivatives and their therapeutic applications |
| 02/22/2001 | CA2391319A1 Water soluble sdz-rad esters |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2383268A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 02/22/2001 | CA2382749A1 Amines substituted with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381978A1 Ppar.delta. links apc to chemopreventive drugs |
| 02/22/2001 | CA2381971A1 Amines substituted with a tetrahydroquinolinyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological acitity |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2381352A1 Phenanthroline-7-one derivatives and their therapeutic uses |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380966A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | CA2380940A1 Substances and agents for positively influencing collagen |
| 02/22/2001 | CA2380936A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | CA2380912A1 Methods and materials for the treatment of prostatic carcinoma |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2380786A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | CA2380753A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | CA2379544A1 New stilbenes with vascular damaging activity |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/21/2001 | EP1077218A2 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076704A1 Il-2 selective agonists and antagonists |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076663A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/21/2001 | EP1076652A1 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 02/21/2001 | EP1076651A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP1076568A1 Non-invasive methods to detect prostate cancer |
| 02/21/2001 | EP1076561A2 Combination therapy for the treatment of tumors |
| 02/21/2001 | EP1076560A1 Inhibition of protein kinases with piridinylimidazoles |
| 02/21/2001 | EP1076486A1 Culture of sessile marine animals |
| 02/21/2001 | EP0871470A4 Haemopoietic growth factor antagonists and uses therefor |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0527852B2 Method and compositions for treating injury |
| 02/21/2001 | CN1284994A Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/21/2001 | CN1284875A Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 02/21/2001 | CN1284566A Preparation process of Lidamycin as one antineoplastic antibiotics |
| 02/21/2001 | CN1062181C Compound sophore flavescens injection |